X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ACHL

Closed

Achilles Therapeutics Plc Adr

1.48
0.00 (0.00%)
Last Update: 26 Mar 2025 16:30:00
Yesterday: 1.48
Day's Range: 1.48 - 1.48
Send
When Written:
 
0.9602
Achilles Therapeutics PLC ADR is a biopharmaceutical company that focuses on the development of personalized cancer immunotherapies. The company is based in the United Kingdom and was founded in 2016. Achilles Therapeutics utilizes its proprietary technology platform to develop T cell therapies that target patient-specific mutations in cancer cells. The company's lead product candidate, called AT-101, is currently in clinical trials for the treatment of solid tumors. Achilles Therapeutics is listed on the NASDAQ stock exchange under the ticker symbol "ACHL."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X